ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Adverse Event (AE) Management Costs Associated With Immune Checkpoint Inhibitors (ICI) Approved for Various Advanced or Metastatic Cancers in the US
Nov 19, 2024, 10:30 AM
«
1891
1892
1893
1894
1895
1896
1897
1898
1899
(current)
1900
»